Used in pharmaceutical synthesis as a chiral building block for developing active pharmaceutical ingredients, particularly in the production of neuroactive compounds and central nervous system agents. Its structure supports the development of drugs targeting neurological disorders due to the presence of a pyrrolidine ring, which is commonly found in bioactive molecules. Commonly employed in asymmetric synthesis to introduce stereochemical control in drug candidates. Also utilized in the preparation of enzyme inhibitors and receptor ligands where stereochemistry plays a critical role in biological activity.